Your payment is in progress...

Global Autoimmune Disease Therapeutics Market: Size & Forecast With Impact Analysis Of COVID-19 (2021-2025)

Published on: Feb 2021 | From USD $900 | Published By: DAEDAL RESEARCH | Number Of Pages: 82

Scope of the Report

The report titled “Global Autoimmune Disease Therapeutics Market: Size & Forecast with Impact Analysis of COVID-19 (2021-2025)”, provides an in depth analysis of the global autoimmune disease therapeutics market by value, by drug class, by indication, by region, etc. The report provides a regional analysis of the autoimmune disease therapeutics market, including the following regions: North America, Europe, Asia Pacific, Middle East & Africa, and Latin America. The report also provides a detailed analysis of the COVID-19 impact on the autoimmune disease therapeutics market.

The report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall global autoimmune disease therapeutics market has also been forecasted for the period 2021-2025, taking into consideration the previous growth patterns, the growth drivers and the current and future trends.

The global autoimmune disease therapeutics market is fragmented with many major market players operating worldwide. The key players of the autoimmune disease therapeutics market are Roche Holding AG, Pfizer Inc., Johnson & Johnson, and Abbott Laboratories are also profiled with their financial information and respective business strategies.

Country Coverage

North America
Europe
Asia Pacific
Middle East & Africa
Latin America

Company Coverage

Roche Holding AG
Pfizer Inc.
Johnson & Johnson
Abbott Laboratories

Executive Summary

An autoimmune disease is a condition in which the body’s immune system attacks and destroys healthy cells and tissues in the body by mistake. In other words, autoimmune disease arises when the immune system fails to distinguish between the body’s own cells and foreign cells. These diseases can affect any part of the body. Autoimmune disease therapeutics is a form of treatment to calm the overactive immune response, to limit tissue damage, and to reduce pain and inflammation. Treatment can also help in relieving symptoms like pain, swelling, and skin rashes.

There are a lot of therapeutic alternatives available, but no option has a perfect safety profile. Infact, while some treatments have been effective in treating certain autoimmune disorders, no treatment is effective for all autoimmune diseases.

The autoimmune disease therapeutics market can be segmented on the basis of drug class (Immunosuppressant’s, Anti-inflammatory Drug, Interferons, NSAIDs, Antihyperglycemics, and Others); indication (Rheumatoid Arthritis, Multiple Sclerosis, Inflammatory Bowel Disease, Type 1 Diabetes, Psoriasis, and Others); and distribution channel (Hospital & Clinics, Pharmacies, Drug Stores, Online Stores, and Others).

The global autoimmune disease therapeutics market has increased significantly during the years 2018-2020 and projections are made that the market would rise in the next four years i.e. 2021-2025 tremendously. The autoimmune disease therapeutics market is expected to increase due to rapid urbanization, escalating healthcare spending, rising prevalence of autoimmune diseases, favorable government initiatives, etc. Yet the market faces some challenges such as high cost involved, lack of approved treatment for IPF (Idiopathic Pulmonary Fibrosis), etc.

1. Executive Summary

2. Introduction

2.1 Autoimmune Disease: An Overview
2.1.1 Most Common Autoimmune Diseases
2.1.2 Areas Affected by Autoimmune Diseases
2.1.3 Common Autoimmune Disease Symptoms

2.2 Autoimmune Disease Therapeutics: An Overview
2.2.1 Evolution of Autoimmune Disease Treatment Depending on the Severity of the Disease

2.3 Autoimmune Disease Therapeutics Segmentation: An Overview
2.3.1 Autoimmune Disease Therapeutics Segmentation by Drug Class
2.3.2 Autoimmune Disease Therapeutics Segmentation by Indication
2.3.3 Autoimmune Disease Therapeutics Segmentation by Distribution Channel

3. Global Market Analysis

3.1 Global Autoimmune Disease Therapeutics Market: An Analysis

3.1.1 Global Autoimmune Disease Therapeutics Market by Value
3.1.2 Global Autoimmune Disease Therapeutics Market by Drug Class (Anti-inflammatory, Interferons, NSAIDs, Antihyperglycemics and Others)
3.1.3 Global Autoimmune Disease Therapeutics Market by Indication (Rheumatoid Arthritis, Multiple Sclerosis, Inflammatory Bowel Disease, Type 1 Diabetes and Other Indications)
3.1.4 Global Autoimmune Disease Therapeutics Market by Region (North America, Europe, Asia Pacific, Middle East & Africa and Latin America)

3.2 Global Autoimmune Disease Therapeutics Market: Drug Class Analysis

3.2.1 Global Anti-Inflammatory Autoimmune Disease Therapeutics Market by Value
3.2.2 Global Interferons Autoimmune Disease Therapeutics Market by Value
3.2.3 Global NSAIDs Autoimmune Diseases Therapeutics Market by Value
3.2.4 Global Antihyperglycemics Autoimmune Disease Therapeutics Market by Value
3.2.5 Global Others Autoimmune Disease Therapeutics Market by Value

3.3 Global Autoimmune Disease Therapeutics Market: Indication Analysis

3.3.1 Global Rheumatoid Arthritis Therapeutics Market by Value
3.3.2 Global Type 1 Diabetes Therapeutics Market by Value
3.3.3 Global Multiple Sclerosis Therapeutics Market by Value
3.3.4 Global Inflammatory Bowel Disease Therapeutics Market by Value
3.3.5 Global Other Indications Therapeutics Market by Value

4. Regional Market Analysis

4.1 North America Autoimmune Disease Therapeutics Market: An Analysis
4.1.1 North America Autoimmune Disease Therapeutics Market by Value

4.2 Europe Autoimmune Disease Therapeutics Market: An Analysis
4.2.1 Europe Autoimmune Disease Therapeutics Market by Value

4.3 Asia Pacific Autoimmune Disease Therapeutics Market: An Analysis
4.3.1 Asia Pacific Autoimmune Disease Therapeutics Market by Value

4.4 Middle East & Africa Autoimmune Disease Therapeutics Market: An Analysis
4.4.1 Middle East & Africa Autoimmune Disease Therapeutics Market by Value

4.5 Latin America Autoimmune Disease Therapeutics Market: An Analysis
4.5.1 Latin America Autoimmune Disease Therapeutics Market by Value

5. Impact of COVID-19

5.1 Impact of COVID-19
5.1.1 Impact of COVID-19 on Healthcare Sector
5.1.2 Impact of COVID-19 on Autoimmune Disease Therapeutics

6. Market Dynamics

6.1 Growth Driver
6.1.1 Rapid Urbanization
6.1.2 Escalating Healthcare Spending
6.1.3 Rising Prevalence of Autoimmune Diseases
6.1.4 Favorable Government Initiatives

6.2 Challenges
6.2.1 High Cost Involved
6.2.2 Lack of Approved Treatment for IPF (Idiopathic Pulmonary Fibrosis)

6.3 Market Trends
6.3.1 Innovations in the Treatment of Autoimmune Diseases
6.3.2 Growing Adoption of JAK Inhibitors for the Treatment of Autoimmune Diseases
6.3.3 Increasing Awareness among Patients towards the Autoimmune Diseases and Therapeutic Treatments

7. Competitive Landscape

7.1 Global Autoimmune Disease Therapeutics Market Players: A Financial Comparison
7.2 Global Autoimmune Disease Therapeutics Market Players by Development of Drugs for IMIDs Targeting JAK

8. Company Profiles

8.1 Roche Holding AG
8.1.1 Business Overview
8.1.2 Financial Overview
8.1.3 Business Strategy

8.2 Pfizer Inc.
8.2.1 Business Overview
8.2.2 Financial Overview
8.2.3 Business Strategy

8.3 Johnson & Johnson
8.3.1 Business Overview
8.3.2 Financial Overview
8.3.3 Business Strategy

8.4 Abbott Laboratories
8.4.1 Business Overview
8.4.2 Financial Overview
8.4.3 Business Strategy

List of Figures

Figure 1: Most Common Autoimmune Diseases
Figure 2: Areas Affected by Autoimmune Diseases
Figure 3: Common Autoimmune Disease Symptoms
Figure 4: Evolution of Autoimmune Diseases Treatment Depending on the Severity of the Disease
Figure 5: Autoimmune Disease Therapeutics Segmentation by Drug Class
Figure 6: Autoimmune Disease Therapeutics Segmentation by Indication
Figure 7: Autoimmune Disease Therapeutics Segmentation by Distribution Channel
Figure 8: Global Autoimmune Disease Therapeutics Market by Value; 2018-2020 (US$ Billion)
Figure 9: Global Autoimmune Disease Therapeutics Market by Value; 2021-2025 (US$ Billion)
Figure 10: Global Autoimmune Disease Therapeutics Market by Drug Class; 2020 (Percentage, %)
Figure 11: Global Autoimmune Disease Therapeutics Market by Indication; 2020 (Percentage, %)
Figure 12: Global Autoimmune Disease Therapeutics Market by Region; 2020 (Percentage, %)
Figure 13: Global Anti-Inflammatory Autoimmune Disease Therapeutics Market by Value; 2018-2020 (US$ Billion)
Figure 14: Global Anti-Inflammatory Autoimmune Disease Therapeutics Market by Value; 2021-2025 (US$ Billion)
Figure 15: Global Interferons Autoimmune Disease Therapeutics Market by Value; 2018-2020 (US$ Billion)
Figure 16: Global Interferons Autoimmune Disease Therapeutics Market by Value; 2021-2025 (US$ Billion)
Figure 17: Global NSAIDs Autoimmune Disease Therapeutics Market by Value; 2018-2020 (US$ Billion)
Figure 18: Global NSAIDs Autoimmune Disease Therapeutics Market by Value; 2021-2025 (US$ Billion)
Figure 19: Global Antihyperglycemics Autoimmune Disease Therapeutics Market by Value; 2018-2020 (US$ Billion)
Figure 20: Global Antihyperglycemics Autoimmune Disease Therapeutics Market by Value; 2021-2025 (US$ Billion)
Figure 21: Global Others Autoimmune Disease Therapeutics Market by Value; 2018-2020 (US$ Billion)
Figure 22: Global Others Autoimmune Disease Therapeutics Market by Value; 2021-2025 (US$ Billion)
Figure 23: Global Rheumatoid Arthritis Therapeutics Market by Value; 2018-2020 (US$ Billion)
Figure 24: Global Rheumatoid Arthritis Therapeutics Market by Value; 2021-2025 (US$ Billion)
Figure 25: Global Type 1 Diabetes Therapeutics Market by Value; 2018-2020 (US$ Billion)
Figure 26: Global Type 1 Diabetes Therapeutics Market by Value; 2021-2025 (US$ Billion)
Figure 27: Global Multiple Sclerosis Therapeutics Market by Value; 2018-2020 (US$ Billion)
Figure 28: Global Multiple Sclerosis Therapeutics Market by Value; 2021-2025 (US$ Billion)
Figure 29: Global Inflammatory Bowel Disease Therapeutics Market by Value; 2018-2020 (US$ Billion)
Figure 30: Global Inflammatory Bowel Disease Therapeutics Market by Value; 2021-2025 (US$ Billion)
Figure 31: Global Other Indications Therapeutics Market by Value; 2018-2020 (US$ Billion)
Figure 32: Global Other Indications Therapeutics Market by Value; 2021-2025 (US$ Billion)
Figure 33: North America Autoimmune Disease Therapeutics Market by Value; 2018-2020 (US$ Billion)
Figure 34: North America Autoimmune Disease Therapeutics Market by Value; 2021-2025 (US$ Billion)
Figure 35: Europe Autoimmune Disease Therapeutics Market by Value; 2018-2020 (US$ Billion)
Figure 36: Europe Autoimmune Disease Therapeutics Market by Value; 2021-2025 (US$ Billion)
Figure 37: Asia Pacific Autoimmune Disease Therapeutics Market by Value; 2018-2020 (US$ Billion)
Figure 38: Asia Pacific Autoimmune Disease Therapeutics Market by Value; 2021-2025 (US$ Billion)
Figure 39: Middle East & Africa Autoimmune Disease Therapeutics Market by Value; 2018-2020 (US$ Billion)
Figure 40: Middle East & Africa Autoimmune Disease Therapeutics Market by Value; 2021-2025 (US$ Billion)
Figure 41: Latin America Autoimmune Disease Therapeutics Market by Value; 2018-2020 (US$ Billion)
Figure 42: Latin America Autoimmune Disease Therapeutics Market by Value; 2021-2025 (US$ Billion)
Figure 43: Global Urbanization Rates by Region; 2010-2040 (Percentage, %)
Figure 44: Global Healthcare Spending; 2017-2022 (US$ Billion)
Figure 45: Global Prevalence of Diagnosed Autoimmune Conditions by Region; 2019 (Percentage, %)
Figure 46: Roche Holding AG Sales; 2016-2020 (US$ Billion)
Figure 47: Roche Holding AG Sales by Segments; 2020 (Percentage, %)
Figure 48: Roche Holding AG Sales by Region; 2020 (Percentage, %)
Figure 49: Pfizer Inc. Revenues; 2019-2020 (US$ Billion)
Figure 50: Pfizer Inc. Revenues by Segments; 2020 (Percentage, %)
Figure 51: Pfizer Inc. Revenues by Region; 2020 (Percentage, %)
Figure 52: Johnson & Johnson Sales; 2015-2019 (US$ Billion)
Figure 53: Johnson & Johnson Sales by Segments; 2019 (Percentage, %)
Figure 54: Johnson & Johnson Sales by Region; 2019 (Percentage, %)
Figure 55: Abbott Laboratories Net Sales; 2015-2019 (US$ Billion)
Figure 56: Abbott Laboratories Net Sales by Segments; 2019 (Percentage, %)
Figure 57: Abbott Laboratories Net Sales by Region; 2019 (Percentage, %)
Table 1: Global Autoimmune Disease Therapeutics Market Players: A Financial Comparison; 2019/2020
Table 2: Global Autoimmune Disease Therapeutics Market by Development of Drugs for IMIDs Targeting JAK

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.

FAQs

Market research is a defined process to collect information about customers, competitors, and everything that a business needs to understand to sustain and grow. It offers important analysis to distinguish and examine the market needs, size, and trends. Market research is generally divided into, primary research and/or secondary research.

The process usually includes collection and interpretation of market data by using statistical and analytical techniques to support the decision making process.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Market research reports provide in-depth analysis about the market conditions and requirements for effective decision making.
The report provides a snapshot of the global market size, segmentation data, marketing growth strategies, market share, export and import information, analysis and forecast of market trends, competition, domestic production, best sales prospects, statistical data, tariffs, regulations, distribution and business practices, end-user analysis, contact points and more.

These research reports include information about competitive strategies, solutions, fact-based research, key takeaways, recommendations, market considerations, emerging business models and market opportunities for multiple segments of an industry.

Market research reports assist in solving business problems and making better decisions to improve business as per the prevalent market trends.
When you place an order with MarketInsightsReports, we try our best to deliver the product as soon as possible. The report will be delivered to you either by email or by physical delivery. If it’s delivered by email the order will be dispatched on the same working day or on the next working day of receipt of payment (unless otherwise specified on our website). There may be exceptions to this if you place order on a non-working day specifically because our publisher partners are located all over the globe. In case of physical delivery report will be couriered to you within 3 working days from the date of the receipt of payment and delivery time will differ based on your location

Any person who has the capacity to make decisions for the business must buy the reports. These reports help management in decision making process. Market research helps person to obtain market information from different sources, and in multiple formats. It aims to study supply and demand, analyze data as per geography, age factors, demography, technology, product, psychographic & gender differences, and many other parameters. Access to in-depth market trends helps person to assess the market effectiveness. Some of the multiple techniques used for market research include customer analysis, choice modeling, competition and risk analysis, product research, advertising the research, marketing mix modeling, simulated test marketing, and more.
Market research studies several features of business environment, such as competitors, market structure, government regulations, economic trends, technological advances and financial analysis of companies, industries, and sectors. This helps person in the decision-making process of planning and implementing strategies for their markets.

The generation of research report is concerned by most clients when purchasing it. Following general steps are taken for generating reports.
1. Choose a topic.
2. Make skeleton catalogue.
3. Fill content. As for report content, there are two main information source, Primary and Secondary data collection. Secondary data collectionrefers to information searched from the Internet or data bought from database. Primary data collection refers to information concluded from telephone interview, face-to-face interview, expert’s interview, meeting etc.
4. Audit the report
5. Publish the report.

With regard to information cost, information searching costs the least, database support the second least, and telephone interview the third least. Face-face interview cost higher, in-depth interview much higher and expert interview the highest. A research may adopt all of these approaches, or just some of them.
In general, a good-quality research report needs 1-3 months to be finished. Time and method varies according to different Publishers. Thus, it’s difficult to define an exact procedure or process of making research report. Both time and cost vary. However, specialization has become a basic industry standard. Professional and dedicated products will be more and more popular.
MarketInsightsReports has focused on various fields such as Life Science, IT, Telecommunication, Food& Beverages, Energy & Power, Automotive & Transportation, Materials& Chemicals, Financial Services and many more. These market research reports are available for all regions around the globe.
When you place an order with MarketInsightsReports, we try our best to deliver the product as soon as possible. The report will be delivered to you either by email or by physical delivery. If it’s delivered by email the order will be dispatched on the same working day or on the next working day of receipt of payment (unless otherwise specified on our website).

There may be exceptions to this if you place order on a non-working day specifically because our publisher partners are located all over the globe. In case of physical delivery report will be couriered to you within 3 working days from the date of the receipt of payment and delivery time will differ based on your location

Please Choose License Type

USD $900
USD $1500
Offer

Why Us

  • Why Us In-depth database
    Our Report’s database covers almost all topics of all regions over the Globe..
  • Recognised publishing sources Recognised publishing sources
    Tie ups with top publishers around the globe.
  • Customer Support Customer Support
    Complete pre and post sales support.
  • Safe & Secure Safe & Secure
    Complete secure payment process.